evidence: The WHO, the European Medicines Agency, and the IDSA all recommend against the use of ivermectin for treatment of COVID-19, with the NIH stating that there is insufficient data to recommend for or against its use outside the context of a clinical trial. - ^ "WHO advises that ivermectin only be used to treat COVID-19 within clinical trials". Newsroom. World Health Organization. Geneva, Switzerland. 31 March 2021. Retrieved 12 May 2023. - ^ "EMA advises against use of ivermectin for the prevention or treatment of COVID-19 outside randomised clinical trials". News. European Medicines Agency. Amsterdam. 22 March 2021. Retrieved 12 May 2023.